Adam Stenman

1.8k total citations
51 papers, 934 citations indexed

About

Adam Stenman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Adam Stenman has authored 51 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Adam Stenman's work include Adrenal and Paraganglionic Tumors (22 papers), Thyroid Cancer Diagnosis and Treatment (17 papers) and Cancer, Hypoxia, and Metabolism (14 papers). Adam Stenman is often cited by papers focused on Adrenal and Paraganglionic Tumors (22 papers), Thyroid Cancer Diagnosis and Treatment (17 papers) and Cancer, Hypoxia, and Metabolism (14 papers). Adam Stenman collaborates with scholars based in Sweden, United States and China. Adam Stenman's co-authors include C. Christofer Juhlin, Jan Zedenius, Catharina Larsson, Anders Höög, Johan O. Paulsson, Tobias Carling, Reju Korah, T Brown, Jill C. Rubinstein and James M. Healy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Adam Stenman

47 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Stenman Sweden 17 578 303 243 229 223 51 934
Alessia Caleo Italy 15 471 0.8× 227 0.7× 310 1.3× 271 1.2× 71 0.3× 38 950
Julie Weng United States 13 747 1.3× 312 1.0× 207 0.9× 504 2.2× 295 1.3× 21 1.3k
Eliška Václavíková Czechia 14 492 0.9× 200 0.7× 161 0.7× 143 0.6× 75 0.3× 33 653
Barbara Cosci Italy 13 1.1k 1.9× 252 0.8× 396 1.6× 300 1.3× 119 0.5× 14 1.3k
Rogier A. Oldenburg Netherlands 18 173 0.3× 241 0.8× 137 0.6× 297 1.3× 329 1.5× 26 846
Andi K. Cani United States 17 223 0.4× 384 1.3× 337 1.4× 273 1.2× 205 0.9× 32 1.1k
Mauro Papotti Italy 15 262 0.5× 287 0.9× 367 1.5× 142 0.6× 147 0.7× 24 937
Thalia Bei United States 12 321 0.6× 514 1.7× 283 1.2× 257 1.1× 208 0.9× 15 1.2k
Vera Paulson United States 12 223 0.4× 158 0.5× 98 0.4× 200 0.9× 85 0.4× 43 710
Marie Ludvíková Czechia 17 242 0.4× 214 0.7× 227 0.9× 323 1.4× 346 1.6× 54 901

Countries citing papers authored by Adam Stenman

Since Specialization
Citations

This map shows the geographic impact of Adam Stenman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Stenman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Stenman more than expected).

Fields of papers citing papers by Adam Stenman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Stenman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Stenman. The network helps show where Adam Stenman may publish in the future.

Co-authorship network of co-authors of Adam Stenman

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Stenman. A scholar is included among the top collaborators of Adam Stenman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Stenman. Adam Stenman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stenman, Adam, Ram Kumar Selvaraju, Hans Lundqvist, et al.. (2025). Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts. Molecular Cancer Therapeutics. 24(5). 753–762. 2 indexed citations
2.
Falhammar, Henrik, Adam Stenman, C. Christofer Juhlin, & Anna Kistner. (2024). Adrenal tumors in patients with neuroendocrine neoplasms. Endocrine. 85(1). 356–362.
3.
Stenman, Adam, Kenbugul Jatta, Vincenzo Condello, et al.. (2024). Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice. Endocrine Pathology. 35(4). 411–418. 2 indexed citations
4.
Svahn, Fredrika, Adam Stenman, Jan Calissendorff, et al.. (2024). Genetic variants and down-regulation of CACNA1H in pheochromocytoma. Endocrine Related Cancer. 31(9). 1 indexed citations
5.
Stenman, Adam, et al.. (2023). TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?. Endocrine Pathology. 34(1). 129–141. 6 indexed citations
6.
Stenman, Adam, Henrik Falhammar, Jan Zedenius, & C. Christofer Juhlin. (2023). Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series. Endocrine. 82(3). 631–637.
7.
Juhlin, C. Christofer, et al.. (2022). Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?. Endocrine Pathology. 33(4). 525–527. 1 indexed citations
8.
Stenman, Adam, Magnus Kjellman, Jan Zedenius, & C. Christofer Juhlin. (2022). Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature. Thyroid Research. 15(1). 1–1. 11 indexed citations
9.
Stenman, Adam, Minjun Yang, Johan O. Paulsson, et al.. (2021). Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma. Cancers. 13(24). 6340–6340. 23 indexed citations
10.
Yao, Shi, Juan Yuan, Vilma Rraklli, et al.. (2021). Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors. Nucleic Acids Research. 49(5). 2509–2521. 10 indexed citations
11.
Paulsson, Johan O., Adam Stenman, Jan Zedenius, et al.. (2021). Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?. Journal of Clinical Pathology. 75(10). 658–662. 5 indexed citations
12.
Jatta, Kenbugul, et al.. (2020). Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential. Journal of Molecular Diagnostics. 23(2). 212–222. 16 indexed citations
13.
Stenman, Adam, Kenbugul Jatta, Renske Altena, et al.. (2020). Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case. Endocrine Pathology. 31(1). 77–83. 7 indexed citations
14.
Juhlin, C. Christofer, Inga‐Lena Nilsson, Kristina Lagerstedt‐Robinson, et al.. (2019). Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center. Modern Pathology. 32(8). 1082–1094. 36 indexed citations
15.
16.
17.
Yuan, Xiaotian, Ninni Mu, Na Wang, et al.. (2018). GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression. Oncogene. 38(7). 965–979. 51 indexed citations
18.
Cheng, J, T Brown, Timothy D. Murtha, et al.. (2017). A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis. BMC Cancer. 17(1). 164–164. 12 indexed citations
19.
Kunstman, John W., C. Christofer Juhlin, Gerald Goh, et al.. (2015). Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Human Molecular Genetics. 24(8). 2318–2329. 267 indexed citations
20.
Stenman, Adam, Fredrika Svahn, Jenny Welander, et al.. (2014). Immunohistochemical NF1 Analysis Does not Predict NF1 Gene Mutation Status in Pheochromocytoma. Endocrine Pathology. 26(1). 9–14. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessia Caleo Breakdown of academic impact, for papers by Julie Weng Breakdown of academic impact, for papers by Eliška Václavíková Breakdown of academic impact, for papers by Barbara Cosci Breakdown of academic impact, for papers by Rogier A. Oldenburg Breakdown of academic impact, for papers by Andi K. Cani Breakdown of academic impact, for papers by Mauro Papotti Breakdown of academic impact, for papers by Thalia Bei Breakdown of academic impact, for papers by Vera Paulson Breakdown of academic impact, for papers by Marie Ludvíková
Rankless by CCL
2026